ClinVar Miner

Variants studied for urinary bladder neoplasm

Included ClinVar conditions (12):
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign other not provided total
178 287 130 16 1 23 33 654

Gene and significance breakdown #

Total genes and gene combinations: 43
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance likely benign benign other not provided total
TP53 11 119 0 0 0 0 0 126
RB1 11 4 102 1 0 0 0 118
TSC1 7 0 2 0 0 0 33 42
FGFR3 15 7 12 5 1 0 0 37
PIK3CA 1 32 0 0 0 0 0 33
HRAS, LRRC56 7 13 7 4 0 0 0 26
MRE11 0 0 0 0 0 23 0 23
CTNNB1, LOC126806658 2 21 0 0 0 0 0 22
ARID1A 20 0 1 0 0 0 0 21
BRCA2 20 0 0 0 0 0 0 20
KRAS 5 1 4 6 0 0 0 16
ERBB2 5 10 0 0 0 0 0 15
ATM 12 0 0 0 0 0 0 12
BRAF 0 11 0 0 0 0 0 11
NF1 11 0 0 0 0 0 0 11
ATM, C11orf65 10 0 0 0 0 0 0 10
FBXW7 0 10 0 0 0 0 0 10
KDM6A 9 0 0 0 0 0 0 9
BRCA1 8 0 0 0 0 0 0 8
ERBB3 4 5 0 0 0 0 0 8
NFE2L2 0 8 0 0 0 0 0 8
NRAS 0 8 0 0 0 0 0 8
CDKN2A 2 5 0 0 0 0 0 7
EGFR 6 0 0 0 0 0 0 6
IDH1 0 5 0 0 0 0 0 5
PTEN 3 1 1 0 0 0 0 5
CREBBP 0 4 0 0 0 0 0 4
ERCC2 4 0 0 0 0 0 0 4
MAP2K1 0 3 0 0 0 0 0 3
SF3B1 0 3 0 0 0 0 0 3
BRCA1, LOC126862571 2 0 0 0 0 0 0 2
CDKN1A 1 0 1 0 0 0 0 2
CNOT9 0 2 0 0 0 0 0 2
EP300 0 2 0 0 0 0 0 2
FGFR1 0 2 0 0 0 0 0 2
LOC110806263, TERT 2 0 0 0 0 0 0 2
MTOR 0 2 0 0 0 0 0 2
RHEB 0 2 0 0 0 0 0 2
RXRA 0 2 0 0 0 0 0 2
U2AF1 0 2 0 0 0 0 0 2
AKT1 0 1 0 0 0 0 0 1
CTNNA3 0 1 0 0 0 0 0 1
MAPK1 0 1 0 0 0 0 0 1

Submitter and significance breakdown #

Total submitters: 12
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance likely benign benign other not provided total
Database of Curated Mutations (DoCM) 0 280 0 0 0 0 0 280
Laboratory of Urology, Hospital Clinic de Barcelona 150 0 6 0 0 0 0 156
Baylor Genetics 1 2 96 0 0 0 0 99
Fulgent Genetics, Fulgent Genetics 18 0 27 16 1 0 0 62
Tuberous sclerosis database (TSC1) 0 0 0 0 0 0 33 33
Gray Institute for Radiation Oncology & Biology, University of Oxford 0 0 0 0 0 23 0 23
Juno Genomics, Hangzhou Juno Genomics, Inc 5 2 2 0 0 0 0 9
OMIM 5 0 0 0 0 0 0 5
Mendelics 1 2 0 0 0 0 0 3
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago 2 0 1 0 0 0 0 3
Bioinformatics dept., Datar Cancer Genetics Limited, India 1 0 0 0 0 0 0 1
Genomic Center, National Cancer Institute 0 1 0 0 0 0 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.